Indication
ATRT R
1 clinical trial
4 products
3 drugs
Clinical trial
A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma, Ependymoma and ATRTStatus: Recruiting, Estimated PCD: 2026-04-01
Drug
AtezolizumabProduct
ThalidomideDrug
CelecoxibProduct
Fenofibric acidProduct
EtoposideDrug
cyclophosphamideProduct
Cytarabine